Natriumchlorid Fresenius (Sodium Chloride)

Sodium chloride delivers Na+ and Cl- ions that increase extracellular osmolarity, drawing water into the bloodstream. This raises plasma volume and restores normal sodium and chloride concentrations, supporting fluid balance and cellular function.

The dose of Natriumchlorid Fresenius is determined by the prescribing clinician based on the patient’s clinical condition, electrolyte levels, and fluid requirements. Healthcare professionals calculate the appropriate volume and concentration for each individual case.

Safety data for Natriumchlorid Fresenius in pregnancy or lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Natriumchlorid Fresenius provides a standard isotonic sodium chloride formulation, similar to other 0.9% saline solutions. Compared with balanced electrolyte solutions, it contains only Na+ and Cl‑, making it suitable when a simple chloride‑based replacement is required, but it lacks additional buffers such as lactate or acetate.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintain the original packaging until use to preserve sterility and solution integrity.

It is administered intravenously by slow infusion through a suitable vein or central line. The infusion rate and total volume are set by the prescriber according to the patient’s fluid and electrolyte needs, following institutional protocols.

Serious risks include anaphylactic reactions, severe hypervolemia, metabolic acidosis, and cardiac arrhythmias. These events are rare but require immediate medical attention if they occur.

Patients with known hypersensitivity to sodium chloride, those with uncontrolled fluid overload, severe renal impairment without appropriate monitoring, or individuals for whom rapid infusion could cause cardiovascular compromise should not receive this product.